Edsivo (celiprolol), being developed by Acer Therapeutics, is one step closer to approval for the treatment of…
Alice Melao
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Alice Melao
A multidisciplinary pain program, which includes medication and self-management strategies, helps patients with Ehlers-Danlos syndrome cope with chronic pain and improve their…
October has been designated as the month to increase awareness on dysautonomia, a complex group of diseases caused by abnormalities…
Early recognition of patients affected by Ehlers-Danlos syndrome (EDS) is important to prevent painful complications of the disease that…
A case of vascular Ehlers-Danlos syndrome (vEDS) which appeared as a rapidly growing neck mass was reported by researchers at…
Abnormal Blood Vessel Communication May Support Early Diagnosis of Vascular EDS, Researchers Suggest
A type of abnormal communication between the main blood vessels in the head, called carotid-cavernous fistula, may be the first…
Acer Therapeutics is planning to request approval for its investigative therapy Edsivo (celiprolol) to treat patients with vascular…